Comparison | Data structure | Type of test | Mean diff. (95% CI) | |
---|---|---|---|---|
a | PSD95, EAE-V versus Sham-V | Normal | One-way ANOVA, Sidak post hoc | –0.24 (–0.45 to –0.02) |
b | PSD95, EAE-099 versus EAE-V | Normal | One-way ANOVA, Sidak post hoc | 0.25 (0.01 to 0.48) |
c | EAE score (IHC cohort), EAE-099 versus EAE-V | Non-parametric | Mann–Whitney U test | –0.5 (–2.5 to 0.5)* |
d | EAE score (conditioning cohort), EAE-099 versus EAE-V | Non-parametric | Mann–Whitney U test | –1 (–1 to 0)* |
e | Microglia SA:volume, EAE-V versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | –0.98 (–1.54 to –0.43) |
f | Microglia SA:volume, EAE-099 versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | –1.09 (–1.64 to –0.53) |
g | Microglia SA:volume, EAE-1134 versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | –0.81 (–1.33 to –0.28) |
h | Iba1, EAE-099 versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | 0.44 (0.05 to 0.82) |
i | CD68, EAE-V versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | 0.73 (–0.26 to 1.71) |
j | iNOS, EAE-V versus Sham-V | Normal | One-way ANOVA, Sidak post hoc | 0.93 (0.29 to 1.57) |
k | iNOS, EAE-099 versus EAE-V | Normal | One-way ANOVA, Sidak post hoc | –0.61 (–1.23 to –0.01) |
l | FcyR1-CD64, EAE-V versus Sham-V | Normal | One-way ANOVA, Sidak post hoc | 0.56 (0.16 to 0.95) |
m | Pro-IL1β, EAE-V versus Sham-V | Normal | One-way ANOVA, Sidak post hoc | 0.87 (–0.02 to 1.77) |
n | CD86, EAE-099 versus EAE-V | Normal | One-way ANOVA, Sidak post hoc | –0.22 (–0.39 to –0.05) |
o | Iba1, EAE-V versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | 5.69 (0.63 to 10.75) |
p | Iba1, EAE-099 versus EAE-V | Normal | One-way ANOVA, Tukey post hoc | 7.75 (3.27 to 12.24) |
q | C1q, EAE-V versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | 2.63 (0.62 to 4.63) |
r | C1q, EAE-099 versus Sham-V | Normal | One-way ANOVA, Tukey post hoc | 3.01 (1.37 to 4.65) |
s | Neuronal apoptosis, 100 nM 099 versus vehicle (24 h) | Normal | One-way ANOVA, Sidak post hoc | –37.0 (–23.2 to –50.8) |
t | Neuronal apoptosis, 300 nM 099 versus vehicle (24 h) | Normal | One-way ANOVA, Sidak post hoc | –38.2 (–24.4 to –52.0) |
u | Neuronal apoptosis, 100 nM 099 versus vehicle (48 h) | Normal | One-way ANOVA, Sidak post hoc | –40.8 (–27.0 to –54.6) |
v | Neuronal apoptosis, 300 nM 099 versus vehicle (248 h) | Normal | One-way ANOVA, Sidak post hoc | –53.9 (–40.1 to –67.7) |
w | P Ser 73 JUN, 099 versus vehicle (8h) | Normal | One-way ANOVA, Sidak post hoc | –0.80 (–0.14 to –1.45) |
x | P Ser 73 JUN, 099 versus vehicle (12h) | Normal | One-way ANOVA, Sidak post hoc | –0.99 (–0.33 to –1.64) |
y | Context Δ freeze, EAE-V versus Sham-V (treatment main effect) | Normal | Two-way ANOVA, Sidak post hoc | –0.33 (–0.61 to –0.05) |
z | Context Δ freeze, EAE-099 versus EAE-V (treatment main effect) | Normal | Two-way ANOVA, Sidak post hoc | 0.32 (0.02 to 0.62) |
↵* Mann–Whitney U test results reported for days with greatest mean difference between group scores (IHC cohort: days 5–6; fear conditioning cohort: days 10–12).